Cambridge, United Kingdom

Joana De Abreu Carvalho

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Joana De Abreu Carvalho

Introduction: Joana De Abreu Carvalho is a distinguished inventor based in Cambridge, GB. With a total of two patents to her name, she has made significant strides in the fields of medicine and biotechnology. Her work focuses on novel therapeutic approaches that hold promise for the treatment and prevention of various diseases.

Latest Patents: Joana's latest patents include groundbreaking inventions such as anti-OPG antibodies and TIGIT antibodies. The first patent, related to anti-OPG antibodies, encompasses methods of treatment, uses, and pharmaceutical compositions aimed at preventing and treating pulmonary arterial hypertension (PAH). The second patent focuses on antibodies specific for various antigens, including bispecific antibodies and immunocytokines, along with their methods of use in vivo.

Career Highlights: Joana has developed her career at Kymab Limited, a company dedicated to advancing antibody therapeutics. Her innovative work at Kymab highlights her commitment to improving patient outcomes through cutting-edge research and development.

Collaborations: Joana collaborates with prominent colleagues such as Rachael Jane Kimber and Jamie Iain Campbell. These partnerships are instrumental in facilitating the transformation of her research ideas into viable medical solutions.

Conclusion: Joana De Abreu Carvalho exemplifies the spirit of innovation in the biotechnology sector. Her patents not only represent significant clinical advancements, but also underscore the collaborative efforts of her colleagues at Kymab Limited. As she continues to push the boundaries of scientific research, her contributions will undoubtedly have a lasting impact on the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…